Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Acta Dermato-Venereologica
|
May 26, 2020
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase
Valerie Glutsch, Teresa Amaral, Claus Garbe, et al.
Arzneimittel-Forschung
|
May 9, 1998
Antibacterial and sebosuppressive efficacy of a combination of chloramphenicol and pale sulfonated shale oil. Multicentre, randomized, vehicle-controlled, double-blind study on 91 acne patients with acne papulopustulosa (Plewig and Kligman's grade II-III)
J W Fluhr, M Gloor, W Merkel, et al.
Cancer Immunology, Immunotherapy : CII
|
January 13, 2021
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Valerie Glutsch, Hermann Kneitz, Anja Gesierich, et al.
Physical Review Letters
|
February 15, 2001
Field-induced delocalization and Zener breakdown in semiconductor superlattices
B Rosam, D Meinhold, F Löser, et al.
The British Journal of Dermatology
|
November 28, 2019
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease
J Weber, V Glutsch, E Geissinger, et al.
Acta Dermato-Venereologica
|
January 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study
Simon Goller, Tassilo Dege, Patrick Schummer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 19, 2017
Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression
W G Philipp-Dormston, K Müller, B Novak, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2022
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG
Valerie Glutsch, Patrick Schummer, Hermann Kneitz, et al.
The British Journal of Dermatology
|
November 2, 2021
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathway
K Maurus, C Kosnopfel, H Kneitz, et al.
Oncogene
|
September 26, 2020
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
Christina Jessen, Julia K C Kreß, Apoorva Baluapuri, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Acta Dermato-Venereologica
|
May 26, 2020
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate Dehydrogenase
Valerie Glutsch, Teresa Amaral, Claus Garbe, et al.
Arzneimittel-Forschung
|
May 9, 1998
Antibacterial and sebosuppressive efficacy of a combination of chloramphenicol and pale sulfonated shale oil. Multicentre, randomized, vehicle-controlled, double-blind study on 91 acne patients with acne papulopustulosa (Plewig and Kligman's grade II-III)
J W Fluhr, M Gloor, W Merkel, et al.
Cancer Immunology, Immunotherapy : CII
|
January 13, 2021
Activity of ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma
Valerie Glutsch, Hermann Kneitz, Anja Gesierich, et al.
Physical Review Letters
|
February 15, 2001
Field-induced delocalization and Zener breakdown in semiconductor superlattices
B Rosam, D Meinhold, F Löser, et al.
The British Journal of Dermatology
|
November 28, 2019
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease
J Weber, V Glutsch, E Geissinger, et al.
Acta Dermato-Venereologica
|
January 20, 2026
Perioperative Pembrolizumab in Locally Advanced Melanoma: A Real-world Single-centre Retrospective Study
Simon Goller, Tassilo Dege, Patrick Schummer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 19, 2017
Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression
W G Philipp-Dormston, K Müller, B Novak, et al.
Journal for Immunotherapy of Cancer
|
November 30, 2022
Ipilimumab plus nivolumab in avelumab-refractory Merkel cell carcinoma: a multicenter study of the prospective skin cancer registry ADOREG
Valerie Glutsch, Patrick Schummer, Hermann Kneitz, et al.
The British Journal of Dermatology
|
November 2, 2021
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathway
K Maurus, C Kosnopfel, H Kneitz, et al.
Oncogene
|
September 26, 2020
The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression
Christina Jessen, Julia K C Kreß, Apoorva Baluapuri, et al.
Page
of 5